120 related articles for article (PubMed ID: 17132363)
1. Warfarin for atrial fibrillation.
Sidhu J; Oakeshott P
Br J Gen Pract; 2006 Nov; 56(532):886. PubMed ID: 17132363
[No Abstract] [Full Text] [Related]
2. [Antithrombotic treatment in atrial fibrillation. Background to new recommendations and therapeutic alternative].
Själander A; Wallentin L; Rosenqvist M; Svensson P
Lakartidningen; 2008 Sep 10-16; 105(37):2478-80. PubMed ID: 19006862
[No Abstract] [Full Text] [Related]
3. Anticoagulation for stroke prevention in elderly patients with atrial fibrillation, including those with falls and/or early-stage dementia: a single-center, retrospective, observational study.
Jacobs LG; Billett HH; Freeman K; Dinglas C; Jumaquio L
Am J Geriatr Pharmacother; 2009 Jun; 7(3):159-66. PubMed ID: 19616184
[TBL] [Abstract][Full Text] [Related]
4. [Complicated priorities regarding antithrombotic treatment of atrial fibrillation. Difficult to understand priority list in the national guidelines--new studies can make them clearer].
Mooe T
Lakartidningen; 2008 Sep 10-16; 105(37):2472-3. PubMed ID: 19006861
[No Abstract] [Full Text] [Related]
5. Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
Hylek EM; Evans-Molina C; Shea C; Henault LE; Regan S
Circulation; 2007 May; 115(21):2689-96. PubMed ID: 17515465
[TBL] [Abstract][Full Text] [Related]
6. Letter regarding article by Hylek et al, "Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation".
Ono A; Kawamura I; Fujita T
Circulation; 2007 Nov; 116(20):e538. PubMed ID: 17998467
[No Abstract] [Full Text] [Related]
7. Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Hylek EM
Thromb Haemost; 2008 Jul; 100(1):16-7. PubMed ID: 18612532
[No Abstract] [Full Text] [Related]
8. Bleeding rates in elderly patients on vitamin K antagonist therapy for nonvalvular atrial fibrillation.
Tay KH; Lip GY; Lane DA
Blood Coagul Fibrinolysis; 2009 Jul; 20(5):392-3. PubMed ID: 19542940
[No Abstract] [Full Text] [Related]
9. Pro: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Why warfarin should really be the drug of choice for stroke prevention in elderly patients with atrial fibrillation.
Mant JW
Thromb Haemost; 2008 Jul; 100(1):14-5. PubMed ID: 18612531
[No Abstract] [Full Text] [Related]
10. [Prevention of thrombosis with warfarin or acetylsalicylic acid related to the risk of hemorrhage].
Andersen P; Smith P; Ovrebø J
Tidsskr Nor Laegeforen; 1992 Mar; 112(9):1222-3. PubMed ID: 1579955
[No Abstract] [Full Text] [Related]
11. Risk factors for bleeding during anticoagulation of atrial fibrillation in older and younger patients in clinical practice.
Abdelhafiz AH; Wheeldon NM
Am J Geriatr Pharmacother; 2008 Mar; 6(1):1-11. PubMed ID: 18396243
[TBL] [Abstract][Full Text] [Related]
12. Newly detected atrial fibrillation and compliance with antithrombotic guidelines.
Glazer NL; Dublin S; Smith NL; French B; Jackson LA; Hrachovec JB; Siscovick DS; Psaty BM; Heckbert SR
Arch Intern Med; 2007 Feb; 167(3):246-52. PubMed ID: 17296879
[TBL] [Abstract][Full Text] [Related]
13. Is age a risk factor for warfarin-related major bleeds in elderly patients with atrial fibrillation?
Cheng HY
J Am Geriatr Soc; 2006 Jul; 54(7):1155. PubMed ID: 16866702
[No Abstract] [Full Text] [Related]
14. Post-stenting antithrombotic drug therapy in patients with atrial fibrillation.
Lip GY
Am J Med; 2007 Nov; 120(11):920-2. PubMed ID: 17976413
[No Abstract] [Full Text] [Related]
15. Compliance with antithrombotic prescribing guidelines for patients with atrial fibrillation--a nationwide descriptive study in Taiwan.
Lin LJ; Cheng MH; Lee CH; Wung DC; Cheng CL; Kao Yang YH
Clin Ther; 2008 Sep; 30(9):1726-36. PubMed ID: 18840379
[TBL] [Abstract][Full Text] [Related]
16. [The influence of CYP2C9 genetic polymorphism on the pharmacokinetics and pharmacodynamics of warfarin in patients with constant atrial fibrillation].
Sychev DA; Mikheeva IuA; Kropacheva ES; Ignat'ev IV; Bulytova IuM; Ramenskaia GV; Dobrovol'skiĭ AB; Panchenko EP; Kukes VG
Klin Med (Mosk); 2007; 85(1):57-60. PubMed ID: 17419358
[TBL] [Abstract][Full Text] [Related]
17. [Between Scylla and Charybdis].
Brean A
Tidsskr Nor Laegeforen; 2009 Jun; 129(13):1322. PubMed ID: 19561655
[No Abstract] [Full Text] [Related]
18. Risk of major bleeding with concomitant dual antiplatelet therapy after percutaneous coronary intervention in patients receiving long-term warfarin therapy.
DeEugenio D; Kolman L; DeCaro M; Andrel J; Chervoneva I; Duong P; Lam L; McGowan C; Lee G; DeCaro M; Ruggiero N; Singhal S; Greenspon A
Pharmacotherapy; 2007 May; 27(5):691-6. PubMed ID: 17461704
[TBL] [Abstract][Full Text] [Related]
19. Stroke risk in atrial fibrillation patients on warfarin. Predictive ability of risk stratification schemes for primary and secondary prevention.
Poli D; Antonucci E; Grifoni E; Abbate R; Gensini GF; Prisco D
Thromb Haemost; 2009 Feb; 101(2):367-72. PubMed ID: 19190823
[TBL] [Abstract][Full Text] [Related]
20. Intensity of anticoagulation in octogenarians with nonvalvular atrial fibrillation.
Jolobe OM
J Am Geriatr Soc; 2008 Oct; 56(10):1967-8. PubMed ID: 19054207
[No Abstract] [Full Text] [Related]
[Next] [New Search]
